Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 4e-07 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |